Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Current Leases: 2011-2024

Historic Current Leases for Niagen Bioscience (NAGE) over the last 11 years, with Dec 2024 value amounting to $982,000.

  • Niagen Bioscience's Current Leases fell 3.17% to $976,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $976,000, marking a year-over-year decrease of 3.17%. This contributed to the annual value of $982,000 for FY2024, which is 42.11% up from last year.
  • Niagen Bioscience's Current Leases amounted to $982,000 in FY2024, which was up 42.11% from $691,000 recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Current Leases ranged from a high of $982,000 in FY2024 and a low of $528,000 during FY2021.
  • In the last 3 years, Niagen Bioscience's Current Leases had a median value of $691,000 in 2023 and averaged $784,333.
  • As far as peak fluctuations go, Niagen Bioscience's Current Leases decreased by 10.36% in 2021, and later spiked by 42.11% in 2024.
  • Niagen Bioscience's Current Leases (Yearly) stood at $589,000 in 2020, then declined by 10.36% to $528,000 in 2021, then climbed by 28.79% to $680,000 in 2022, then climbed by 1.62% to $691,000 in 2023, then soared by 42.11% to $982,000 in 2024.